Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore effective ways to live frugally and build wealth. Smart choices can enhance your financial stability.
28,655 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A $1,000 investment in XRP at $0.50 grew to about $7,300 at the 2025 high. With XRP near $1.40 in 2026, investors won...
NVIDIA's Huang warns of a potential AI leadership shift as Huawei accelerates its chip ambitions. Markets react as in...
Mizuho raises Dell's price target to $300 on expected durable demand from agentic AI servers, while UBS nudges valuat...
Alphabet and Amazon are issuing investment-grade debt at scale, drawing funds away from U.S. Treasuries. The shift pl...
Tokenized equities daily volume reached a new all-time high of $3.57 billion, according to The Block. The milestone p...
Meta Platforms delivered a strong Q1 with revenue eclipsing expectations while signaling heavier AI-driven capital ou...
Credo Technology stock sits near its 52-week peak as AI infrastructure demand remains robust. Investors are debating ...
A bold forecast from Moonshot AI’s Kimi model envisions a wide end-2026 Bitcoin range, with potential upside to $180,...
A $10,000 position in ETHU’s 2x Ether ETF has collapsed to a fraction of its starting value as daily compounding and ...
New data show housing demand growth reflects a split in local markets, where some areas see price adjustments and lar...
SpaceX used its soaring stock to fund a $60 billion Cursor acquisition in stock, turning a fresh IPO into a powerful ...